Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$47.98 - $54.4 $250,647 - $284,185
5,224 New
5,224 $283,000
Q2 2023

Aug 14, 2023

BUY
$63.71 - $70.74 $4,332 - $4,810
68 Added 2.07%
3,348 $214,000
Q1 2023

May 15, 2023

BUY
$65.71 - $74.53 $5,651 - $6,409
86 Added 2.69%
3,280 $227,000
Q4 2022

Feb 14, 2023

SELL
$68.48 - $81.09 $60,262 - $71,359
-880 Reduced 21.6%
3,194 $229,000
Q3 2022

Nov 14, 2022

BUY
$0.13 - $76.84 $529 - $313,046
4,074 New
4,074 $292,000
Q3 2021

Nov 15, 2021

SELL
$59.17 - $69.31 $179,876 - $210,702
-3,040 Closed
0 $0
Q2 2021

Aug 16, 2021

SELL
$61.91 - $67.42 $1.69 Million - $1.84 Million
-27,312 Reduced 89.98%
3,040 $201,000
Q1 2021

May 17, 2021

SELL
$59.34 - $66.74 $298,954 - $336,236
-5,038 Reduced 14.24%
30,352 $1.92 Million
Q4 2020

Mar 05, 2021

BUY
$57.74 - $65.43 $265,084 - $300,389
4,591 Added 14.91%
35,390 $2.19 Million
Q3 2020

Nov 16, 2020

SELL
$57.43 - $63.64 $99,870 - $110,669
-1,739 Reduced 5.34%
30,799 $1.85 Million
Q2 2020

Aug 14, 2020

BUY
$54.82 - $64.09 $358,303 - $418,892
6,536 Added 25.14%
32,538 $1.88 Million
Q1 2020

May 15, 2020

BUY
$46.4 - $67.43 $110,617 - $160,753
2,384 Added 10.09%
26,002 $1.41 Million
Q4 2019

Feb 14, 2020

BUY
$49.21 - $64.19 $446,826 - $582,845
9,080 Added 62.46%
23,618 $1.51 Million
Q3 2019

Nov 14, 2019

BUY
$42.77 - $50.71 $16,209 - $19,219
379 Added 2.68%
14,538 $730,000
Q2 2019

Aug 14, 2019

BUY
$44.62 - $49.34 $32,751 - $36,215
734 Added 5.47%
14,159 $639,000
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $48,729 - $58,104
1,080 Added 8.75%
13,425 $642,000
Q4 2018

Feb 14, 2019

BUY
$48.76 - $63.23 $36,765 - $47,675
754 Added 6.51%
12,345 $629,000
Q3 2018

Nov 14, 2018

BUY
$55.19 - $62.25 $177,270 - $199,947
3,212 Added 38.33%
11,591 $718,000
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $160,634 - $200,213
-3,179 Reduced 27.5%
8,379 $463,000
Q1 2018

May 15, 2018

SELL
$59.92 - $68.98 $30,858 - $35,524
-515 Reduced 4.27%
11,558 $723,000
Q4 2017

Feb 14, 2018

BUY
$59.94 - $65.35 $90,749 - $98,939
1,514 Added 14.34%
12,073 $746,000
Q3 2017

Nov 14, 2017

BUY
$55.23 - $63.74 $583,173 - $673,030
10,559
10,559 $665,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Voya Financial Advisors, Inc. Portfolio

Follow Voya Financial Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Financial Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Voya Financial Advisors, Inc. with notifications on news.